Oncology & Hematology Coding Alert
Code Correctly With Brachytherapy Checklist
Know service level, delivery method before coding When you're reporting prostate brachytherapy treatment, you must know the delivery method and the level of treatment intensity. 1. Report liquid radioactive sources with 77750 (Infusion or instillation of radioelement solution [includes three months follow-up care]).
Help your office keep things straight by posting this list of CPT codes to use with different prostate brachytherapy treatments. This chart will help you when you're wondering how many levels of service exist for interstitial radiation source application. (There are three, by the way.)
2. Report interstitial radiation source application with one of these:
3. Report brachytherapy with ultrasound with 76965 (Ultrasonic guidance for interstitial radioelement application).
Oncology & Hematology Coding Alert
- Part II:
Prostate Brachytherapy From Pre- to Post-Implant Sim
Don't report a liquid radioactive source code for seeds In addition to the initial visit [...] - You Be the Coder:
How Many G Codes Does Demo Project Demand?
Question: Our office is participating in the Medicare demonstration project for chemotherapy patients. I was [...] - Clip and Save:
Code Correctly With Brachytherapy Checklist
Know service level, delivery method before coding When you're reporting prostate brachytherapy treatment, you must [...] - Extra E/M Time Not Always a Prolonged Service
Some chemo patients may need more time to review materials When your oncologist spends 80 [...] - News You Can Use:
CMS Clarifies Push/Infusion Issue
Use initial IV push codes for infusions of 30 minutes or less Medicare has made [...] - If Counseling Extends Encounter, Shelf Prolonged Service Codes
Sometimes, raising the E/M level is the better option In certain cases of longer-than-normal evaluation [...] - Reader Questions:
Pump Refill Code Not for Port Flushings
Question: We recently performed a port flush on a patient with an implanted pump. We [...] - Reader Questions:
Post-Chemo Nausea Med Is Separately Reportable
Question: If we give a Medicare patient an intravenous dose of ondansetron after a chemotherapy [...]
